Fresenius Medical Care is taking the next step in extracorporeal life support with Xenios 2.0
15. October 2024
Fresenius Medical Care’s heart & lung business unit, Xenios AG, introduces the all-new Xenios 2.0. This system enables healthcare professionals to take the next step in extracorporeal life support (ECLS). It can be used for the full range of ECLS treatments, from neonatal to adult patients, and is approved ...
ESICM LIVES congress 2024
Thank You, ESICM LIVES 2024!
What an incredible 37th Annual ESICM LIVES Congress in Barcelona!
A huge thank you to the organizers, speakers, and participants for delivering an inspiring and informative event. Looking forward to implementing the takeaways and staying connected with the brilliant minds we met during the congress. Until ...
ESPNIC congress 2024
20. June 2024
A heartfelt thank you to all ESPNIC congress 2024 and symposium attendees!
Our deepest gratitude to everyone who participated in the ESPNIC congress 2024 and the accompanying lunch symposium. Your presence, engagement, and contributions made this event an outstanding success!
It was an honor to connect with so many dedicated healthcare ...
Info
Not all products or services presented on this website are cleared or available for sale in all countries. For further information on country-specific regulations, please contact your local Xenios AG representative.
Also, the information on this website is not intended for an audience within the USA. If your are from the USA, please visit the corresponding Fresenius Medical Care website here